Indication

T-cell Lymphomas

1 clinical trial

1 product

Clinical trial

A Phase 1/2 Study of the Safety, Tolerability, Pharmacokinetics, and Efficacy of BMS-986369 in Participants With Relapsed or Refractory T-cell Lymphomas in Japan

Status: Recruiting, Estimated PCD: 2027-01-01

Product